期刊文献+

人工肝血浆置换治疗慢性重型肝炎80例临床分析 被引量:6

Clinical Analysis of 80 Patients with Chronic Severe Hepatitis Treated with Artificial Liver(Plasma Exchange)
下载PDF
导出
摘要 目的:观察80例经人工肝血浆置换治疗的慢性重型肝炎患者的转归,评价人工肝血浆置换治疗对慢性重型肝炎的临床作用。方法:80例慢性重型肝炎患者在内科综合治疗的基础上予以等量冰冻血浆进行血浆置换(plasma exchange,PE)治疗,观察治疗前后肝肾功能、电解质、血氨、凝血酶原时间、血常规的变化情况。结果:与血浆置换前相比,治疗后患者的血常规、电解质、肾功能无明显变化,总胆红素、血清谷丙转氨酶(ALT)降低(P<0.01),凝血酶原时间缩短(P<0.01),胆碱酯酶升高(P<0.01)。80例慢性重型肝炎患者总死亡率为41.25%。结论:血浆置换是一种有效的人工肝支持疗法,对慢性重型肝炎有肯定和可靠的辅助支持与治疗作用。人工肝治疗进行得越早,疗效越好。掌握好治疗时机是提高疗效的关键所在。 Objective:To evaluate the clinical effects of plasma exchange for treating of chronic severe hepatitis. Methods:Eighty patients with chronic severe hepatitis were treated with plasma exchange using same volume of freeze plasma in addition to the medicine comprehensive treatment. Results: Serum cholinesterase of an patients were in- creased significantly ( P 〈 0.01 ), while the serum bilirubin, ALT, PT were decreased ( P 〈 0.01 ) than tha before the treatment. The total death rate of 80 patients was 41.25%. Conclusions:The plasma exchange is a kind of effective ar- tificial liver support therapy ,having affirmative and dependable effect of support and treatment in patients with chronic severe hepatitis. The earlier artificial liver treatment carry on, the better curative effect is. The correct opportunity and selection of relevant patients is a key factor that improve the curative effect.
出处 《透析与人工器官》 2006年第3期11-13,共3页 Chinese Journal of Dialysis and Artificial Organs
关键词 重型肝炎 血浆置换 Severe hepatitis, Plasma exchange
  • 相关文献

参考文献5

二级参考文献12

  • 1[4]Hirasawa H, Sugai T, Oda S, et al. Efficacy and limitation of apheresis therapy in critical care[J]. Therap Ahperesis, 1997, 1:228- 232.
  • 2[6]Yoshiba M, Inovue K, Sekiyama K et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure[J]. Artif Organs, 1996,20:1169 - 1172.
  • 3贞广智仁,平泽博之,营井桂雄,他.Critical Care にぉけるCHDF の cytokine除支效果おょびその机序につて[J].日ケフェしシス会志,1999,(18):41-47.
  • 4门野润,上本伸二,猪股裕纪洋,他.剧症肝不全症例に( )する生体肝移植の神经学的予后の检讨[J].肝脏,2001,(42):15-21.
  • 5[10]Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure [J]. Hepatology, 2000, 32:734 - 739.
  • 6[11]Nagaki M, I wai H, Naiki T, et al. High levels of serum interleukin -10 and tumor necrosis factor α are associated with fatality in fulminant hepatitis[J] .J Infect Dis,2000, 182:1103- 1108.
  • 7平泽博之,织田成人,志贺英敏,他.Critical careにおける持统的血液滤过透析(CHDF)のnon-renal indication[J].透析会志,2000,(33):171-173.
  • 8平野刚,平泽博之,织田成人,他.剧症肝炎(FH)に( )する肝移植の适应と bridge use としての人工肝补助疗法[J].集中治疗,2000,(12):865-872.
  • 9[15]Watanabe FD, Mullon CJ- P, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure [J]. Ann Surg, 1997,225:484 - 494.
  • 10[16]STockmann HBAC, Hiemstra CA, Marquet RL, et al. Extracorporeal perfusion for the treatment of acute liver failure[J].Ann Sure 2000,231:460 - 470.

共引文献14030

同被引文献48

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部